Experience with using alternative reducing agents at blast furnace
作者:J. Buchwalder、T. Fuchs、J. Hunger、T. Siepert
DOI:10.1051/metal:2003177
日期:2003.3
This paper presents the experience that EKO Stahl has gained with the blast furnace injection of plastics and animal fats as alternative reducing agents since 1993. The specific pieces of equipment that have been designed and implemented for handling, storing and injecting these substances into the blast furnace tuyeres are described. The parameters that allow line stability and the overall effects on blast furnace operation are reported.
The photochemical or thermal rearrangement of oxaziranes as a method in alkaloid synthesis
作者:Martin E. Kuehne、W.H. Parsons
DOI:10.1016/s0040-4020(01)88617-8
日期:1983.1
The conversion of cyclic ketones to β-arylethyl amine derived imines, their oxidation to oxaziranes and subsequent photochemical rearrangement to N-(β-arylethyl) lactams was probed as a potential method for alkaloid syntheses.
Amidino dervatives useful as nitric oxide synthase inhibitors
申请人:G. D. Searle & Co.
公开号:US05854234A1
公开(公告)日:1998-12-29
The current invention discloses useful pharmaceutical compositions containing azepine derivatives useful as nitric oxide synthase inhibitors.
本发明公开了含有用作一氧化氮合酶抑制剂的氮杂环衍生物的有用药物组合物。
Amidino derivatives useful as nitric oxide synthase inhibitors
申请人:G.D. Searle & Co.
公开号:US06046211A1
公开(公告)日:2000-04-04
The current invention discloses useful pharmaceutical compositions containing amidino derivative useful as nitric oxide synthase inhibitors.
本发明公开了含有作为一氧化氮合酶抑制剂的有用酰胺基衍生物的有用药物组合物。
Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
作者:Hongfu Lu、Ting Yang、Zhongmiao Xu、Xichen Lin、Qian Ding、Yueting Zhang、Xin Cai、Kelly Dong、Sophie Gong、Wei Zhang、Metul Patel、Royston C. B. Copley、Jianing Xiang、Xiaoming Guan、Paul Wren、Feng Ren
DOI:10.1021/acs.jmedchem.7b01854
日期:2018.3.22
pharmacology with excellent selectivity over CXCR1 and other chemokine receptors. Rat and dog pharmacokinetics (PK) revealed good oral bioavailability, high oral exposure, and desirable elimination half-life of the compound in both species. In addition, the compound demonstrated dose-dependent efficacy in the in vivo pharmacology neutrophil infiltration “air pouch” model in rodents after oral administration. Further